Stevens Capital Management’s Novavax NVAX Stock Holding History

Stevens Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,820	Closed	-$257K	–	1064
2015 Q3	$257K	Buy	+1,820	New	+$408K	0.01%	749
2014 Q4	–	Sell	-1,141	Closed	-$95K	–	1160
2014 Q3	$95K	Buy	+1,141	New	+$103K	﹤0.01%	937
2014 Q2	–	Sell	-943	Closed	-$85K	–	1235
2014 Q1	$85K	Sell	943 -502	-35%	-$56.1K	﹤0.01%	1014
2013 Q4	$148K	Buy	+1,445	New	+$102K	﹤0.01%	940

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stevens Capital Management's NVAX Position: Q4 2015 in Review

Stevens Capital Management sold out of Novavax (NVAX) in Q4 2015, closing a stake of 1,820 shares — an estimated $257K sold.

Stevens Capital Management first reported a position in NVAX in Q4 2013 and held it in 4 quarters. The position peaked at $257K in Q3 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

Stevens Capital Management reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
Stevens Capital Management sold 1,820 Novavax shares in Q4 2015, an estimated $257K.
Stevens Capital Management first reported a position in Novavax in Q4 2013 and held it in 4 quarters.
Stevens Capital Management's Novavax position peaked at $257K in Q3 2015.
173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on Stevens Capital Management's 13F filing for Q4 2015, filed 5 Feb 2016.